Patent · US Active

Rapidly dispersible dosage form of topiramate

US9492380B2 · kind B2 · utility

7Cited by
20References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2015
Grant dateNov 15, 2016
Priority date
Expiry dateAug 27, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A taste-masked rapidly dispersible dosage form of topiramate is provided. Wax coated particles of topiramate are included within a porous bound matrix. The topiramate retains its taste-masked form after dispersion in the mouth of a subject even though the particles are not coated with a polymeric material. The dosage form disperses in saliva or water in less than 2 min even though it has a high content of wax. It can be used to treat diseases or disorders that are therapeutically responsive to topiramate or a derivative thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.